Evidence map›Paper›PMID 26783429›Full record

ArticleClinical case reports2016

A case of neurolymphomatosis caused by follicular lymphoma successfully treated with bendamustine.

Masayuki Umeda, Tadakazu Kondo, Momoko Nishikori, Toshiyuki Kitano, Masakatsu Hishizawa, Norimitsu Kadowaki, Akifumi Takaori-Kondo

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Masayuki UmedaDepartment of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Tadakazu KondoDepartment of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Momoko NishikoriDepartment of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Toshiyuki KitanoDepartment of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Masakatsu HishizawaDepartment of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Norimitsu KadowakiDepartment of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Akifumi Takaori-KondoDepartment of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Kyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, there is no standard treatment for neurolymphomatosis because of the scarcity of clinical studies. Here, we report the successful treatment of neurolymphomatosis caused by follicular lymphoma with bendamustine, which could be an effective treatment option for this condition.

Indexed as

Bendamustineblood‐nerve barrierfollicular lymphomaneurolymphomatosis

Identifiers

PMID26783429
PMCPMC4706405
OpenAlexW2134950042

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.